Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026 
Asian Stocks Rise on AI Optimism and Iran Peace Talk Hopes 
UK Wage Growth Slows to 3.6% as Inflation Pressures Complicate Bank of England Outlook 
NASA and SpaceX Target Crew-11 Undocking From ISS Amid Medical Concern 
Anthropic CEO Meets Trump Officials to Discuss Powerful New AI Model Mythos 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
Uranium Bull Market Gains Momentum Amid Supply Deficits and Geopolitical Tensions 
AEVEX Raises $320 Million in IPO Amid Surging Defense Sector Demand 
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology 
Oil Prices Surge Amid Middle East Tensions as Global Markets React Cautiously 
Rising Jet Fuel Costs from Iran Conflict Push Airfare Higher Across Europe 
Polymarket Seeks $400M Funding Round, Targets $15B Valuation Amid Prediction Market Boom 
US-Iran Peace Talks Fuel Market Optimism Amid Ongoing Tensions 
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 
CDC Acting Director Urges Measles Vaccination as U.S. Cases Surge in 2026 
South Korea will invest 274.6 billion won in the bio-industry this year for 252 new R&D projects in the four fields of biopharmaceuticals, healthcare, biomaterials, and medical equipment in 2023.
According to South Korea’s Ministry of Trade, Industry and Energy, 94.8 billion won would be allocated to developing new medicines, microbiome analysis, and other biomanufacturing process technology.
Around 69.5 billion won will support the development of advanced medical appliances, and 30 billion won will be for developing state-of-the-art biomaterials.
The ministry added that beefing up support for biomaterials and other new fields of the sector would promote innovation.
